$ICPT INTERCEPT PHARMACEUTICALS, INC. Insiders

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in INTERCEPT PHARMACEUTICALS, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of current and past insiders in INTERCEPT PHARMACEUTICALS, INC.. Find out how many shares they currently own, their value and whether they buy or sell their shares.

INTERCEPT PHARMACEUTICALS, INC. Insiders

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Adorini LucianoChief Scientific Officer12,6081,431,891Oct 05 2015
Adorini LucianoChief Scientific Officer5,094578,526Jul 24 2013
Adorini LucianoChief Scientific Officer6,392725,939Jan 03 2014
AKKARAJU SRINIVASDirector477,12954,187,541shares bought: 676,705 / shares sold: -23,438 STRONG BUYMar 12 202116 months ago
AKKARAJU SRINIVASDirector2,368268,934Dec 19 2013
AKKARAJU SRINIVASDirector7,642867,902Nov 13 2014
BALL BRYANChief Quality Officer25,0002,839,250shares bought: 25,000 / shares sold: 0 BUYJan 11 202118 months ago
Benatti LucaDirector1,292146,732Dec 15 2014
BRADBURY DANIELDirector15,8111,795,655shares bought: 47,059 / shares sold: 0 STRONG BUYJun 01 202113 months ago
Bright LisaPresident, International22,0122,499,903shares bought: 29,553 / shares sold: -22,630 BUYJul 06 202024 months ago
Campagna JasonChief Medical Officer20,5312,331,706shares bought: 16,800 / shares sold: -2,760 STRONG BUYJan 26 202117 months ago
Cawkwell GailSVP, Med Affairs, Safety & PV32,5533,697,044shares bought: 22,784 / shares sold: -4,201 STRONG BUYMay 13 202114 months ago
Duncan Barbara GayleChief Accounting Officer30,6613,482,170shares bought: 0 / shares sold: -437 STRONG SELLOct 05 2016
Duncan Barbara GayleChief Financial Officer9,4101,068,694Oct 03 2013
Duncan Barbara GayleChief Financial Officer10,7081,216,108Jan 03 2014
Duncan Barbara GayleChief Financial Officer14,8081,681,745Jul 03 2014
Duncan Barbara GayleChief Financial Officer17,2641,960,672Jan 07 2015
Durso Jerome BenedictPresident & CEO82,1429,328,867shares bought: 94,600 / shares sold: -7,401 STRONG BUYApr 05 202115 months ago
Ford David AChief Human Resources Officer23,7112,692,858shares bought: 29,200 / shares sold: -3,609 STRONG BUYMay 11 202114 months ago
Freedberg JaredGeneral Counsel and Secretary44,2775,028,539shares bought: 44,277 / shares sold: 0 BUYFeb 01 202117 months ago
Fundaro PaoloDirector5,417,000615,208,690shares bought: 14,328 / shares sold: -2,097,749 STRONG SELLAug 17 202023 months ago
Fundaro PaoloDirector8,803999,757Aug 12 2014
Genextra S.p.A.10% Owner5,417,000615,208,690shares bought: 390,625 / shares sold: -4,632,312 STRONG SELLAug 17 202023 months ago
Gottesdiener Keith MichaelDirector9,9531,130,362shares bought: 13,466 / shares sold: 0 STRONG BUYJun 01 202025 months ago
Kapadia SandipCFO and Treasurer40,9644,652,281shares bought: 56,200 / shares sold: -9,208 STRONG BUYJan 26 202117 months ago
Kim Richard JPresident US Comm & Strat Mktg20,8282,365,436shares bought: 15,200 / shares sold: -4,413 STRONG BUYOct 05 202021 months ago
Luca BenattiDirector10,7211,217,584shares bought: 8,779 / shares sold: 0 STRONG BUYJun 01 202025 months ago
McMinn RachelChief Strategy Officer16,8751,916,494shares bought: 5,000 / shares sold: -2,451 BUYOct 04 2017
Micheli Francesco10% Owner5,417,000615,208,690shares bought: 390,625 / shares sold: -2,845,578 STRONG SELLAug 17 202023 months ago
Micheli Francesco10% Owner5,938,890674,479,737Oct 23 2013
Micheli Francesco10% Owner6,454,953733,089,012Apr 11 2014
Miller-Rich NancyDirector7,538856,091shares bought: 7,538 / shares sold: 0 STRONG BUYJun 01 202025 months ago
ORBIMED ADVISORS LLCDirector1,120,609127,267,564Jul 21 2015
ORBIMED ADVISORS LLCDirector1,485,324168,688,247Aug 27 2014
ORBIMED ADVISORS LLCDirector2,151,283244,321,210Apr 15 2013
Patel Sanj KDirector45251,334Jul 21 2014
Pruzanski MarkDirector506,46657,519,344shares bought: 267,940 / shares sold: -216,611 BUYMay 04 202114 months ago
Pruzanski MarkPresident and CEO406,89946,211,519Oct 03 2013
Pruzanski MarkPresident and CEO416,63547,317,237Jan 03 2014
Pruzanski MarkCEO & President491,03255,766,504Jan 07 2015
Pruzanski MarkCEO & President486,62555,266,001Nov 20 2014
Regan Daniel PaulChief Commerical Officer00Mar 06 2013
Regan Daniel PaulChief Commercial Officer00Mar 07 2014
Regan Daniel PaulChief Commercial Officer1,264143,552Jan 07 2015
Regan Daniel PaulChief Commercial Officer1,264143,552Feb 03 2015
Richardson Linda MEVP & Chief Commercial Officer26,8663,051,172shares bought: 5,531 / shares sold: 0 BUYFeb 17 202117 months ago
SANTINI GINODirector8,8791,008,388shares bought: 7,579 / shares sold: 0 STRONG BUYJun 01 202025 months ago
SBLENDORIO GLENNDirector15,7101,784,185shares bought: 14,608 / shares sold: 0 STRONG BUYJun 01 202113 months ago
SBLENDORIO GLENNDirector45251,334Jul 21 2014
Shapiro DavidChief Medical Officer41,4994,713,041shares bought: 35,810 / shares sold: -43,121 SELLMay 03 2019
Shapiro DavidCMO & EVP - Development3,000340,710Dec 17 2013
Shapiro DavidCMO and EVP - Development4,623525,034Jan 03 2014
Shapiro DavidCMO and EVP - Development14,2531,618,713Sep 17 2014
Shapiro DavidCMO and EVP - Development18,7962,134,662Feb 19 2015
SILVERSTEIN JONATHANDirector1,259142,985Nov 27 2015
SILVERSTEIN JONATHANDirector28532,367Jul 21 2014
SILVERSTEIN JONATHANDirector60969,164Aug 12 2014
SILVERSTEIN JONATHANDirector1,596,582181,323,818Aug 18 2014
SILVERSTEIN JONATHANDirector1,980224,869Nov 12 2013
SILVERSTEIN JONATHANDirector2,150,634244,247,503Oct 16 2012
Sullivan Ryan TGeneral Counsel and Secretary24,7082,806,088shares bought: 52,550 / shares sold: -30,862 STRONG BUYNov 16 202020 months ago
TALLARIGO LORENZODirector3,479395,110Nov 12 2013
TALLARIGO LORENZODirector00Jul 09 2014
VEITINGER KLAUS R DRDirector2,816319,813Nov 27 2015
VEITINGER KLAUS R DRDirector2,120240,768Nov 12 2013
VEITINGER KLAUS R DRDirector2,166245,993Nov 12 2014
VEITINGER KLAUS R DRDirector2,166245,993Feb 12 2015
Venezia RoccoChief Accounting Officer14,2891,622,802shares bought: 0 / shares sold: -29 STRONG SELLApr 05 202115 months ago
WELCH DANIEL GDirector8,060915,374shares bought: 7,579 / shares sold: -819 STRONG BUYJun 01 202025 months ago
Weyer ChristianEVP, Research & Development27,3413,105,117shares bought: 47,825 / shares sold: -20,879 STRONG BUYApr 05 202115 months ago
WILLIAMS NICOLEDirector962109,254Nov 23 2015
WILLIAMS NICOLEDirector2,569291,761Nov 12 2013
WILLIAMS NICOLEDirector1,465166,380Jan 22 2015
WILLIAMS NICOLEDirector3,304375,235May 09 2014